{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:07:06Z","timestamp":1760188026814},"reference-count":28,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2001,1,1]]},"DOI":"10.1080\/095466301750163527","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T15:31:10Z","timestamp":1027697470000},"page":"19-22","source":"Crossref","is-referenced-by-count":33,"title":["The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum"],"prefix":"10.1080","volume":"12","author":[{"given":"JH","family":"Hagman","sequence":"first","affiliation":[{"name":"University of Rome Tor Vergata, Department of Dermatology, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AM","family":"Carrozzo","sequence":"additional","affiliation":[{"name":"University of Rome Tor Vergata, Department of Dermatology, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Campione","sequence":"additional","affiliation":[{"name":"University of Rome Tor Vergata, Department of Dermatology, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Romanelli","sequence":"additional","affiliation":[{"name":"University of Miami School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Chimenti","sequence":"additional","affiliation":[{"name":"University of Rome Tor Vergata, Department of Dermatology, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"Powell FC, Su WPD, Perry HO, Pyoderma gangrenosum: classification and management J Am Acad Dermatol (1996) 34: 395-409.","DOI":"10.1016\/S0190-9622(96)90428-4"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Lear JT, Atherton MT, Byrne JPH, Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome. Postgrad Med J (1997) 73: 65-8.","DOI":"10.1136\/pgmj.73.856.65"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"Jorizzo JL, Solomon AR, Zanolli MD, Leshin B, Neutrophilic vascular reactions. J Am Acad Dematol (1988) 19: 983-1005.","DOI":"10.1016\/S0190-9622(88)70264-9"},{"key":"CIT0004","doi-asserted-by":"crossref","unstructured":"Schaegerle SM, Bergfeld WF, Senitzer D, Tidrick RT, Pyoderma gangrenosum: a review. J Am Acad Dermatol (1988) 18: 559-68.","DOI":"10.1016\/S0190-9622(88)70080-8"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Gallen JP, Pyoderma gangrenosum. Lancet (1998) 351: 581-5.","DOI":"10.1016\/S0140-6736(97)10187-8"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Levitt MD, Ritchie JK, Leonard-Jones JE, Philips RKS, Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg (1991) 78: 676-8.","DOI":"10.1002\/bjs.1800780613"},{"key":"CIT0007","doi-asserted-by":"crossref","unstructured":"Hava H Wakvi F, Fujitsuka A et al, Subcutaneous abscesses in a patient with ulcerative colitis. J Am Acad Dermatol (2000) 42: 363-5.","DOI":"10.1016\/S0190-9622(00)90113-0"},{"key":"CIT0008","doi-asserted-by":"crossref","unstructured":"Clark HH, Cohen PR, Pyoderma gangrenosum in an HIV-infected patient. J Am Acad Dermatol (1995) 32:912-14.","DOI":"10.1016\/0190-9622(95)91561-3"},{"key":"CIT0009","doi-asserted-by":"crossref","unstructured":"Graham JA. Hansen KK, Rabinowitz LG, Esterly NB. Pyoderma gangrenosum in infants and children. Pediatr Dermatol (1994) 11:10-18.","DOI":"10.1111\/j.1525-1470.1994.tb00065.x"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Glass AT, Bancila E, Milgraum S, Pyoderma gangrenosum in infancy: the youngest reported patient. J Am Acad Dermatol (1991) 25:109-10.","DOI":"10.1016\/S0190-9622(08)80497-5"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Chow RKP, Ho VC, Treatment of pyoderma gangrenosum. J Am Acad Dermatol (1996) 34:1047-60.","DOI":"10.1016\/S0190-9622(96)90285-6"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Von den Driesch P, Pyoderma gangrenosum: a case report of 44 cases with follow-up. Br J Dermatol (1997) 137: 1000-5.","DOI":"10.1046\/j.1365-2133.1997.20022083.x"},{"key":"CIT0013","doi-asserted-by":"crossref","unstructured":"Richter-Hintz D, Schuppe HC, Homey B et al, Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol (2000) 42: 304-5.","DOI":"10.1016\/S0190-9622(00)90149-X"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Wolf R, Nicotine for pyoderma gangrenosum. Arch Dermatol (1998) 134:1071-2.","DOI":"10.1001\/archderm.134.9.1071"},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"Gupta AK, Shear NH, Sauder DN, Efficacy of human intravenous immunoglobuline in pyoderma gangrenosum. J Am Acad Dermatol (1995) 32:140-2","DOI":"10.1016\/0190-9622(95)90218-X"},{"key":"CIT0016","doi-asserted-by":"crossref","unstructured":"Dirscha T, Kastner U, Behrens S, Altmeyer P, Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. J Am Acad Dermatol (1998) 39: 789-90.","DOI":"10.1016\/S0190-9622(98)70052-0"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Dwyer JM, Manipulating the immune system with immune globulin. N Engl J Med(1992) 326:107-16.","DOI":"10.1056\/NEJM199201093260206"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Mouthon L, Kaveri SV, Spalter SH et al. Mechanism of action of intravenous immune globulin in immune mediated diseases. Clin Exp Immunol (1996) 104: 3-9.","DOI":"10.1111\/cei.1996.104.s1.3"},{"key":"CIT0019","doi-asserted-by":"crossref","unstructured":"Basta M Modulation of complement-mediated immune damage by intravenous immune globulin. Clin Exp Immunol (1996) 104:21-5.","DOI":"10.1111\/cei.1996.104.s1.21"},{"key":"CIT0020","doi-asserted-by":"crossref","unstructured":"Andersson J, Skansen-Saphir U, Sparrelid E, Andersson U, Intravenous immune globulin affects cytochine production in T lymphocytes and monocytes\/macrophages. Clin Exp Immunol (1996) 104:10-20.","DOI":"10.1111\/cei.1996.104.s1.10"},{"key":"CIT0021","unstructured":"Gottfried I. Seeber A. Anegg B et al. Established and new therapeutic approaches in dermatomyositis, polimyositis and overlapping syndromes. Wien Klin Wochenschr (1996) 108: 705-76."},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Jolies S, Huges J. Whittaker S, Dermatological uses of highdose intravenous immunoglobulin. Arch Dermatol (1998) 134: 80-6.","DOI":"10.1001\/archderm.134.1.80"},{"key":"CIT0023","doi-asserted-by":"crossref","unstructured":"Messer G, Sizmann N, Feucht H, Meurer M High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris. Br J Dermatol (1995) 133: 1014-16.","DOI":"10.1111\/j.1365-2133.1995.tb06952.x"},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Backers RC, Brand A, Vermeer BJ, Boom BW, Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. Br J Dermatol (1995) 133:289-93.","DOI":"10.1111\/j.1365-2133.1995.tb02631.x"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Mohr C, Sunderkotter C, Hildebrand A et al, Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins. Br J Dermatol (1995) 132: 824-6.","DOI":"10.1111\/j.1365-2133.1995.tb00735.x"},{"key":"CIT0026","doi-asserted-by":"crossref","unstructured":"Sanwo M Nwadiuko R, Beall G, Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS. J Allergy Clin Immunol (1996) 98\/6:1112-15.","DOI":"10.1016\/S0091-6749(96)80199-0"},{"key":"CIT0027","doi-asserted-by":"crossref","unstructured":"Viard I. Wehrli P. Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science (1998) 282:490-3.","DOI":"10.1126\/science.282.5388.490"},{"key":"CIT0028","doi-asserted-by":"crossref","unstructured":"Kimata H, High-dose gammaglobulin treatment for atopic dermatitis. Arch Dis Child(1994) 70: 335-6.","DOI":"10.1136\/adc.70.4.335"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/095466301750163527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T18:37:28Z","timestamp":1661193448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/095466301750163527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1,1]]}},"alternative-id":["10.1080\/095466301750163527"],"URL":"https:\/\/doi.org\/10.1080\/095466301750163527","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1,1]]}}}